Musculoskeletal Diseases Clinical Trial
— COMPISOfficial title:
COMPIS- Congenital Myopathy Intervention Study. An Open-label, Cross Over, Randomised, Controlled Study Using Oral Salbutamol
Verified date | May 2023 |
Source | Vastra Gotaland Region |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Congenital myopathies (CM) is a large group of muscle disorders, presenting with hypotonia and non-progressive generalised muscle weakness, which can lead to motor developmental delay.More than 20 genes can cause CM and currently there is no curative treatment for this disorder. Case reports and a smaller study have previous reported that oral salbutamol has benefited subjects with different types of congenital myopathies by increasing their muscle strength.The exact effect of salbutamol in muscle cells isn't exactly known but it has been hypothesized to have an anabolic effect by triggering different pathways inside the muscle cells which increase cell proliferation, decrease apoptosis, decreases proteolysis and increases protein synthesis. The aim of our study is evaluate if daily oral salbutamol can increase the muscle function and muscle strength in these patients after 6 months on treatment, compared to no treatment.
Status | Enrolling by invitation |
Enrollment | 20 |
Est. completion date | December 31, 2025 |
Est. primary completion date | December 31, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 6 Years to 30 Years |
Eligibility | Inclusion Criteria: - Signed informed consent from legal guardians/patients and patient (where applicable) - Subject must have a confirmed congenital myopathy(CM) diagnosis defined as: - Clinical symptoms consistent with CM with pathohistological findings on muscle biopsy and known genetic mutation consistent with CM OR - Clinical symptoms consistent with CM with unspecific pathohistological changes but known genetic mutation consistent with CM - Stabile motor function tests over at least 6 months (between baseline and screening) - If on other medications- stabile dose for at least 6 months prior to start - At least 1 point on Motor function measure 32 test is (MFM32) at screening visit. >5- <31 years of age (from 6 years to 30 years of age) - Women of fertile age must be on oral contraceptives - Underwent cardiac evaluation with ECG and 2D echocardiography in the last 2 years and has no signs or symptoms of cardiac abnormality. Exclusion Criteria: - Subject with clinical symptoms consistent with CM but has no confirmed genetic mutation and only unspecific changes on muscle biopsy that are not confined to just CM but can be seen in other disorders. - Younger than 6 years of age and older than 30 years - Subject receives 94 or more points on MFM32 test at screening visit. - Subject doesn't not speak Swedish and a translator is needed in order to perform the tests included in the study. - Subject smokes more than 10 cigarettes a day or has smoked more than 10 cigarettes in the last year - Subject has tracheostomy - Subject receives no points on motor function measure test at screening - Subject has other concomitant chronic diagnosis that can affect the patients motor function, in the opinion of the investigator - Subject is currently or has been on oral corticosteroids in the last 6 months - Subject has arrhythmia as seen on electrocardiogram(ECG), confirmed by cardiologist - Subject has cardiomyopathy as seen on ultrasound, confirmed by cardiologist - Subject has severe behavioural and/ cognitive problems that preclude participation in the study, in the opinion of the investigator - Subject is allergic or hypersensitive to study drug or any of its constituents - Subject has previous or ongoing medical condition, medical history, physical findings or laboratory abnormalities that could affect safety, make it unlikely that treatment and follow- up will be correctly completed or impair the assessment of study results, in the opinion of the Investigator; - Subject is currently taking any other investigational drug or has taken any other investigational drug within 3 months prior to the first dose of study medication - Subject is planning on participating in any other study during the duration of this study. - Female subjects of fertile age that are or are planning to become pregnant during the study. - Female subjects that have given birth up to 1 year prior to baseline visit and/or are nursing up to 1 month prior of baseline visit - Subject has a fracture in the last 6 months before the study start or has acquired a fracture during the study. |
Country | Name | City | State |
---|---|---|---|
Sweden | Sahlgrenska university hospital | Gothenburg | Västra Götaland |
Lead Sponsor | Collaborator |
---|---|
Vastra Gotaland Region |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Motor function measure test 32 (MFM32) | score presented as a total score from 0 to 96 points, the higher the score the better motor function | 19 months | |
Secondary | timed function tests | seconds | 5 evaluations in 19 months | |
Secondary | 6 minute walk test | meters/minute for speed calculation, as well as total distance walked. | 5 evaluations in 19 months | |
Secondary | hand grip test | measured in pounds | 5 evaluations in 19 months | |
Secondary | 5 consecutive 9 hole PEG test | measured in seconds | 5 evaluations in 19 months | |
Secondary | muscle myometry test using a hand held myometer | measured in newtons | 5 evaluations in 19 months | |
Secondary | Activity limitation ACTIVLIM- quality of life questionnaire | measured as total score, 0-32 max points, the higher the score the less the limitation in activities | 5 evaluations in 19 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT04976972 -
A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation
|
N/A | |
Recruiting |
NCT05546541 -
Epidemiology and Nutrition
|
||
Completed |
NCT05071469 -
Comparison of Two Different Treatment Methods
|
N/A | |
Completed |
NCT05041400 -
Distribution of Knee Isokinetic Angle-specific Moments and Ratios
|
N/A | |
Not yet recruiting |
NCT06216028 -
Bone Marrow Aspirate Concentrate (BMAC) Treatment for Knee Osteoarthritis
|
Phase 3 | |
Not yet recruiting |
NCT04932993 -
Writing Down Goals
|
N/A | |
Completed |
NCT02944448 -
A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
|
Phase 2 | |
Completed |
NCT02257489 -
Phase 1 Study of ACE-083 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT02256098 -
RSA RCT: ATTUNEā¢ TKA Versus PFC Sigma TKA
|
N/A | |
Completed |
NCT02269254 -
Persona Versus NexGen
|
N/A | |
Completed |
NCT01979731 -
Effects Job Rotation in the Prevention of Work Related Musculoskeletal Disorders
|
N/A | |
Active, not recruiting |
NCT01440153 -
Additional Exercise Program in Professional Dancers
|
N/A | |
Completed |
NCT00968266 -
Improving Beliefs About Medication in Patients With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT05222126 -
Efficacy of Ultrasound-Guided Hydrodissection in Carpal Tunnel Syndrome
|
N/A | |
Completed |
NCT05062694 -
Physical Therapy Management Of The Patient With Central Sensitization
|
||
Recruiting |
NCT05564182 -
High Intensity Laser Therapy in the Treatment of Hemiplegic Shoulder Pain
|
N/A | |
Completed |
NCT04009369 -
Impacts of Physiotherapy Services in a Quebec Emergency Department
|
N/A | |
Completed |
NCT05561452 -
The Efficacy of PRP Injection in the Treatment of Rotator Cuff Syndrome
|
N/A | |
Recruiting |
NCT05432609 -
Standardization and Reproducibility Regarding Scanning Procedures and Measurements of Weight-bearing Cone Beam CT in the Lower Extremity
|
||
Completed |
NCT04959162 -
The Effect of Theoretical Knowledge on Resident's Practical Performance in Musculoskeletal Ultrasound
|
N/A |